Skip to main content
. 2016 Nov 11;41(22):1709–1717. doi: 10.1097/BRS.0000000000001707

TABLE 4.

Adverse Events That Occurred at an Incidence of ≥5%

Placebo n = 224 Duloxetine n = 234 P
Constipation 5 (2.2) 25 (10.7) 0.0002*
Nausea 6 (2.7) 21 (9.0) 0.0049*
Dry mouth 0 (0.0) 14 (6.0) 0.0001*
Nasopharyngitis 39 (17.4) 26 (11.1) 0.0610
Contusion 7 (3.1) 16 (6.8) 0.0867
Somnolence 16 (7.1) 45 (19.2) 0.0002*
Dizziness 2 (0.9) 15 (6.4) 0.0020*

Data are presented as n (%).

*Indicates statistical significance.